Annual ROE
213.71%
+1092.99%+124.31%
December 31, 2023
Summary
- As of February 7, 2025, RVNC annual return on equity is 213.71%, with the most recent change of +1092.99% (+124.31%) on December 31, 2023.
- During the last 3 years, RVNC annual ROE has risen by +307.77% (+327.21%).
- RVNC annual ROE is now at all-time high.
Performance
RVNC ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
135.86%
-100.66%-42.56%
September 30, 2024
Summary
- As of February 7, 2025, RVNC quarterly return on equity is 135.86%, with the most recent change of -100.66% (-42.56%) on September 30, 2024.
- Over the past year, RVNC quarterly ROE has increased by +4101.15% (+103.43%).
- RVNC quarterly ROE is now -72.98% below its all-time high of 502.80%, reached on December 31, 2023.
Performance
RVNC Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
RVNC ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +124.3% | +103.4% |
| 3 y3 years | +327.2% | +218.9% |
| 5 y5 years | +410.6% | +256.1% |
RVNC ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +124.3% | -73.0% | +103.4% |
| 5 y | 5-year | at high | +124.3% | -73.0% | +103.4% |
| alltime | all time | at high | +124.3% | -73.0% | +103.4% |
Revance Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 135.86%(-42.6%) |
| Jun 2024 | - | 236.52%(-38.6%) |
| Mar 2024 | - | 384.94%(-23.4%) |
| Dec 2023 | 213.71%(-124.3%) | 502.80%(-112.7%) |
| Sep 2023 | - | -3965.29%(+245.4%) |
| Jun 2023 | - | -1147.96%(+0.7%) |
| Mar 2023 | - | -1139.44%(+59.5%) |
| Dec 2022 | -879.28%(+592.0%) | -714.37%(+86.4%) |
| Sep 2022 | - | -383.33%(+15.7%) |
| Jun 2022 | - | -331.31%(+55.9%) |
| Mar 2022 | - | -212.53%(+50.1%) |
| Dec 2021 | -127.07%(+35.1%) | -141.59%(+23.9%) |
| Sep 2021 | - | -114.24%(+7.9%) |
| Jun 2021 | - | -105.84%(+12.8%) |
| Mar 2021 | - | -93.80%(+2.2%) |
| Dec 2020 | -94.06%(+9.5%) | -91.78%(-3.2%) |
| Sep 2020 | - | -94.81%(+2.3%) |
| Jun 2020 | - | -92.64%(+9.0%) |
| Mar 2020 | - | -84.97%(-0.7%) |
| Dec 2019 | -85.92%(+24.9%) | -85.53%(-1.7%) |
| Sep 2019 | - | -87.05%(+12.8%) |
| Jun 2019 | - | -77.14%(+7.5%) |
| Mar 2019 | - | -71.75%(+5.0%) |
| Dec 2018 | -68.80% | -68.34%(+3.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | -66.31%(-0.6%) |
| Jun 2018 | - | -66.72%(+2.4%) |
| Mar 2018 | - | -65.17%(+0.1%) |
| Dec 2017 | -54.09%(+30.4%) | -65.11%(+0.2%) |
| Sep 2017 | - | -64.97%(+22.5%) |
| Jun 2017 | - | -53.03%(+10.9%) |
| Mar 2017 | - | -47.83%(+16.1%) |
| Dec 2016 | -41.49%(+21.3%) | -41.19%(+2.2%) |
| Sep 2016 | - | -40.31%(-6.3%) |
| Jun 2016 | - | -43.01%(+4.2%) |
| Mar 2016 | - | -41.26%(-0.7%) |
| Dec 2015 | -34.21%(-94.9%) | -41.55%(+3.7%) |
| Sep 2015 | - | -40.05%(+16.1%) |
| Jun 2015 | - | -34.51%(-2.3%) |
| Mar 2015 | - | -35.34%(-45.6%) |
| Dec 2014 | -668.62%(-2108.5%) | -65.01%(-36.9%) |
| Sep 2014 | - | -103.01%(-53.3%) |
| Jun 2014 | - | -220.48%(-242.3%) |
| Mar 2014 | - | 154.94%(+165.6%) |
| Dec 2013 | 33.29%(+23.8%) | 58.34%(+30.9%) |
| Sep 2013 | - | 44.58%(+117.7%) |
| Jun 2013 | - | 20.48%(+36.4%) |
| Mar 2013 | - | 15.02%(+198.6%) |
| Dec 2012 | 26.88%(-6.8%) | 5.03% |
| Dec 2011 | 28.85% | - |
FAQ
- What is Revance Therapeutics annual return on equity?
- What is the all time high annual ROE for Revance Therapeutics?
- What is Revance Therapeutics annual ROE year-on-year change?
- What is Revance Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Revance Therapeutics?
- What is Revance Therapeutics quarterly ROE year-on-year change?
What is Revance Therapeutics annual return on equity?
The current annual ROE of RVNC is 213.71%
What is the all time high annual ROE for Revance Therapeutics?
Revance Therapeutics all-time high annual return on equity is 213.71%
What is Revance Therapeutics annual ROE year-on-year change?
Over the past year, RVNC annual return on equity has changed by +1092.99% (+124.31%)
What is Revance Therapeutics quarterly return on equity?
The current quarterly ROE of RVNC is 135.86%
What is the all time high quarterly ROE for Revance Therapeutics?
Revance Therapeutics all-time high quarterly return on equity is 502.80%
What is Revance Therapeutics quarterly ROE year-on-year change?
Over the past year, RVNC quarterly return on equity has changed by +4101.15% (+103.43%)